The 2027 edition of the Australian Medicines Handbook is set to be released in January, and the updated guidance is accompanied by a fresh look and new name – AMH Medicines.
The 1000-page handbook is designed to provide clear, comparative information on medicines, practical prescribing and dosing guidance.
It also provides evidence-based clinical recommendations for Australian clinicians and will be available in print and online, reflecting AMH’s digital-first direction.
Among the changes in the 2027 edition are:
new indications, including deucravacitinib for psoriatic arthritis
a review and update on eczema management
revised considerations for periprocedural use of glucagon-like peptide-1 receptor agonists
new information on drug interactions
removal of content about recently discontinued drugs.
The resource also includes information on precautions, adverse effects, monitoring and patient counselling, therapeutic information documents and class statements that support clinical decision-making.




